What Happened
Albert Hofmann, a Swiss chemist working in Basel, stumbled into what became the first recorded LSD experience while researching ergot-derived compounds for possible medical use. What began as routine laboratory work in April 1943 soon turned into one of the most famous episodes in the history of psychopharmacology: a disorienting bicycle ride home, followed by intense hallucinations and a new global conversation about psychedelics.
Hofmann had synthesized lysergic acid diethylamide years earlier while studying compounds from ergot, a fungus tied to medicinal research. He later suspected that a tiny amount may have absorbed through his skin during purification. Curious about the substance’s effects, he returned to it three days later and deliberately took what he believed was a minimal dose. The result was far stronger than expected.
He soon felt ill and began pedaling home from the laboratory through Basel as his vision warped and the world appeared altered. By the time he reached his apartment, familiar objects looked transformed, and even a chair seemed animate. The experience escalated through the night into vivid visions of fear and distortion before easing several hours later.
From Laboratory Curiosity to Psychedelic Symbol
Hofmann’s bicycle trip became one of the most enduring images associated with LSD, later inspiring annual commemorations on April 19. The date is now widely recognized in psychedelic culture as Bicycle Day, marking the moment the compound first revealed its potency in a human being.
The discovery quickly moved beyond personal experimentation. Hofmann reported the effects to his employer, the pharmaceutical company Sandoz, which began supplying LSD to psychiatric hospitals under the name Delysid. In the early years, some psychiatrists explored whether the drug could help patients access suppressed memories or confront mental conflict in therapeutic settings.
At the same time, Hofmann grew wary of casual use. He argued that substances with such profound psychological effects required strict care and expert supervision, drawing a comparison between traditional spiritual use of hallucinogens and modern medical oversight. His concern proved prescient as LSD spread far beyond clinical research.
How LSD Shaped the 1960s
By the 1960s, the drug had escaped laboratory control and entered countercultural life in the United States and beyond. Figures such as novelist Ken Kesey and Harvard psychologist Timothy Leary helped popularize its use, turning LSD into a symbol of rebellion, exploration and experimentation. Leary’s slogan, “turn on, tune in, drop out,” became one of the era’s best-known phrases.
That wider use also brought darker consequences. Users reported so-called bad trips, marked by panic, terror and lasting psychological distress. As more people took LSD outside medical supervision, governments moved toward strict regulation. The United Nations placed it under international control in 1971, and many countries later banned it outright.
Why Hofmann’s Story Still Matters
Hofmann’s experience remains relevant because it sits at the crossroads of science, medicine and public policy. His work reflects an era when pharmaceutical researchers explored natural compounds for potential therapeutic value, while the later spread of LSD helped trigger modern drug-control regimes. That tension still shapes today’s debates over psychedelic medicine, where researchers are again studying whether carefully controlled use may help treat mental health conditions.
Hofmann, who died in 2008 at the age of 102, left behind a complicated legacy. He saw LSD as a powerful substance that could be dangerous in careless hands but meaningful under disciplined use. His own assessment was philosophical as much as scientific: reality, he said, was not fixed, and the experience convinced him that other dimensions of perception existed.